Industries
Top countries
Publication dates
All regions
industry reports
country reports
... Mdx novartis mdx development 28 | systems thinking in personalized medicine | novartis molecular diagnostics | mit systems thinking conference | october2011 diagnostics development As mental ...
... A molecular diagnostic platform that can deliver rapid, low cost results at the point-of-care. Ubi ceo, paul wright said, I am very pleased to announce this licence agreement between two australian ...
... A molecular diagnostic platform that can deliver rapid, low cost results at the point-of-care. Ubi ceo, paul wright said, I am very pleased to announce this licence agreement between two australian ...
... Growing with a cagr of 19 percent global molecular diagnostics market is expected to reach us$ 15 billion by 2014.The fastest growing segment is infectious disease with 21% market share as the dominant ...
... Note: as of 2011 source: seegene, woori i&s research center source: seegene, woori i&s research center 5 seegene www.Wooriwm.Com 2012 p/e and eps growth comparison for global molecular ...
... And operating profit of w3.4Bn). Even though 1q is usually the low season for molecular diagnostics companies, seegene S 1q12 sales are expected to remain flat q-q thanks to a likely sharp increase in sales ...
... Is pursuing other potential large-scale b2b deals, including supply of its molecular diagnostic technology-based products to global pharmas, food players, and medical examination centers. Anticipating ...
... Personalized medicine segments like genetically modified (gm) products, wellness & disease management, targeted biologics, other molecular diagnostics, genomics and proteomics and consumer self diagnostic ...
... Euronext: mdxh), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced results for q4 and full year 2011. Highlights mdx ...
... Technicians. As a result, our xt-8 system can provide national reference laboratories with the ability to perform our menu of molecular diagnostic tests across all of their locations. We also designed our xt-8 ...
» Purchase Premium Reports (From $ 680 - $ 1 160)
2 reports for Molecular Diagnostic
... Disease susceptibility and other molecular diagnostic tests, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products.Contains 32 pages ...
Reportlinker.com © Copyright 2012. All rights reserved